Deepak L Bhatt, MD, MBA, FESC, FACP, FACC
Cardiology — Icahn School of Medicine at Mount Sinai, United States
Deepak L Bhatt
LeadR Profile
Cardiology
Subspecialties: Public Health - Endocrinology - Biochemistry
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
- Top Myocardial Ischemia key opinion leaders — ranked #2
- Top Arterial Occlusive Diseases key opinion leaders — ranked #6
- Top Arteriosclerosis key opinion leaders — ranked #8
- Top Coronary Disease key opinion leaders — ranked #13
- Top Glucose Metabolism Disorders key opinion leaders
- Top Diabetes Mellitus key opinion leaders
Short Biography
Deepak L. Bhatt, MD, MPH, MBA, FACC, FAHA, FESC, MSCAI, is the Director of the Mount Sinai Fuster Heart Hospital and the Dr. Valentin Fuster Professor of Cardiovascular Medicine (with Tenure) at the Icahn School of Medicine at Mount Sinai in New York City.
After graduating as valedictorian from Boston Latin School, Dr. Bhatt obtained his science degree as a National Merit Scholar at MIT, his MD from Cornell, an MPH from Harvard, and an Executive MBA from Oxford. He trained in internal medicine at the University of Pennsylvania and cardiology at Cleveland Clinic. He completed fellowships in interventional cardiology and cerebral and peripheral vascular intervention and served as Chief Interventional Fellow at Cleveland Clinic, where he spent many years as an interventional cardiologist, Associate Professor of Medicine, Director of the Interventional Cardiology Fellowship, Associate Director of the Cardiovascular Medicine Fellowship, and Associate Director of the Cardiovascular Coordinating Center. He then served as the Chief of Cardiology at VA Boston Healthcare System and subsequently as Executive Director of Interventional Cardiovascular Programs at Brigham and Women’s Hospital. He was a Senior Investigator in the TIMI Study Group and Editor-in-Chief of the Harvard Heart Letter. He became a full Professor of Medicine at Harvard Medical School in 2012. Brigham and Women’s Hospital selected him as the 2014 Eugene Braunwald Scholar. He received the Research Mentor Award from Brigham and Women’s Hospital Department of Medicine in 2016, the Eugene Braunwald Teaching Award for Excellence in the Teaching of Clinical Cardiology from Brigham and Women’s in 2017, ACC’s Distinguished Mentor Award in 2018, AHA’s Distinguished Scientist Award in 2019, NLA’s Honorary Lifetime Membership Award in 2021, and SCAI’s Master designation in 2022.
Dr. Bhatt has authored or co-authored over 2300 publications. He is the Editor of Cardiovascular Intervention: A Companion to Braunwald’s Heart Disease and Opie's Cardiovascular Drugs: A Companion to Braunwald's Heart Disease. He is one of the co-Editors of Braunwald’s Heart Disease. He had served as Senior Associate Editor for News and Clinical Trials for ACC.org and is the Editor of the Journal of Invasive Cardiology. He was the PI for CHARISMA, CRESCENDO, COGENT, REDUCE-IT, SOLOIST, SCORED, and ENTRIGUE and co-PI of the three CHAMPION trials, STAMPEDE, SAVOR-TIMI 53, SYMPLICITY HTN-3, THEMIS, THEMIS-PCI, and the REACH registry. In 2014, he was listed in the AHA/ASA top advances in heart disease and stroke research (for STAMPEDE and SYMPLICITY HTN-3); in 2018, REDUCE-IT was listed and also named the top cardiology trial by NEJM; in 2020 and again in 2021, SOLOIST and SCORED were listed by the AHA. He was the inaugural Chair of the AHA-GWTG Quality Oversight Committee, served as a Trustee of the ACC, and currently serves on the Board of Directors and as President of the AHA New York City chapter.
Organizations
Career arc: 1998 - 2026
Number : 3266
Citations
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Incidence, Predictors, and Clinical Impact of Early Readmission After Complex Percutaneous Coronary Intervention. mortality, hospitalization, incidence, percutaneous coronary intervention, cardiology, sex | Am J Cardiol | 2026 | 0 |
| Early Aspirin Discontinuation Following PCI for Acute Coronary Syndromes: A Systematic Review and Meta-Analysis of Reconstructed Individual Patient Data. hemorrhage, percutaneous coronary intervention, acute coronary syndrome, aspirin, therapeutics | J Soc Cardiovasc Angiogr Interv | 2026 | 0 |
| Intracoronary Imaging-Guided Percutaneous Coronary Intervention: An Updated Meta-Analysis of Randomized Trials. stents, mortality, percutaneous coronary intervention, angiography, recipient vessels | J Am Coll Cardiol | 2026 | 1 |
| Five-Year Follow-Up of Transcatheter Aortic Valve Replacement With Self-Expanding Intra-Annular Versus Commercially Available Valves. mortality, stroke, aortic valve, transcatheter aortic valve replacement | JACC Cardiovasc Interv | 2026 | 0 |
| Mitral Regurgitation and Severe Aortic Stenosis: Clinical Characteristics, Prognostic Impact, and Response to TAVR: Insights From Egnite Data. constriction, pathologic, mortality, aortic valve stenosis, cardiovascular surgical procedures, hospitalization, echocardiography, transcatheter aortic valve replacement, therapeutics, mitral valve insufficiency | Circ Cardiovasc Interv | 2026 | 0 |
Clinical Studies 90
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 4
Ongoing Clinical Trials
Ongoing trial started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| One Month DAPT in CABG Patients NCT05997693 — ticagrelor, aspirin, arteries, coronary artery bypass, coronary disease, transplants, therapeutics | Phase 3 | Recruiting | 2024 |
LeadR Networks
Main global connection map